Nar Cancer

The original intention of the founding of Nar Cancer was to provide a high-level communication platform for scholars in the fields of nucleic acid research and cancer research, and to promote cooperation and integration between the two fields. The editor in chief, Professor William S. Dynan, comes from Emory University School of Medicine in the United States, which has laid a solid foundation for the academic orientation and development strategy of the journal. This journal mainly publishes original research, investigation, and summary articles in the interdisciplinary field of nucleic acid research and cancer research, covering cancer computational biology, cancer data resources, DNA damage sensing and repair, gene regulation and chromosome, genomics, methodology, nucleic acid based cancer therapy, and structural biology of cancer-related macromolecules. The publication of these contents not only enriches the theoretical system of cancer research, but also provides important references and guidance for clinical practice.

In summary, Nar Cancer is an academic journal with significant influence in the interdisciplinary field of nucleic acid research and cancer, providing a high-level communication platform for scholars worldwide and promoting cooperation and integration between the two fields.